Eugene OR 乳腺癌临床试验
7项针对 乳腺癌的研究正在 Eugene及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Oncology Associates of Oregon PC, Eugene
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Oncology Associates of Oregon, Eugene
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
招募中1/2 期
- Oncology Associates of Oregon, P.C, Eugene
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
招募中2/3 期
- Willamette Valley Cancer Institute, Eugene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- USOR Oncology Associates of Oregon, P.C., Eugene
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
招募中1/2 期
- Oncology Associates of Oregon, Springfield · 距离 3 英里
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
招募中观察性研究
- Willamette Valley Cancer Institute and Research Center, Eugene
其他城市的 乳腺癌试验
- New York City, NY134 项研究
- Houston, TX126 项研究
- Boston, MA111 项研究
- Nashville, TN80 项研究
- Los Angeles, CA72 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Durham, NC63 项研究
- Queens, NY63 项研究
- Chicago, IL58 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Eugene的其他研究
- 非小细胞肺癌13 项研究
- 卵巢癌9 项研究
- 子宫内膜癌8 项研究
- 慢性淋巴细胞白血病6 项研究
- 多发性骨髓瘤6 项研究
- 转移性癌症6 项研究
- 癌症（所有类型）6 项研究
- 药物使用与成瘾5 项研究
- 肺癌5 项研究
- 黄斑变性5 项研究
- 肥胖症4 项研究
- 前列腺癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。